#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Breast cancer metastatic Non-small cell lung cancer metastatic Type 2 diabetes mellitus More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Piriformis syndrome Lymphoma Hereditary motor and sensory neuropathy Retinal artery occlusion Sexually transmitted disease Langerhans' cell histiocytosis Heavy menstrual bleeding Biotinidase deficiency Meningococcal immunisation Kaposi's sarcoma Sickle cell disease Small intestine leiomyosarcoma Acute lymphocytic leukaemia Lung adenocarcinoma Tourette's disorder More trials…

    Learn about Rare Diseases

    Acquired haemophilia Hepatic angiosarcoma – Diagnostics Erdheim-Chester disease – Basic Information Gastrointestinal stromal tumour – Basic Information Kearns-Sayre syndrome – Basic Information Primary hyperoxaluria – Treatment Rhabdoid tumour Mastocytosis Netherton’s syndrome – Basic Information Friedreich’s ataxia – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Elotuzumab Citalopram Hydrobromide Azenosertib Terlipressin Vidofludimus Calcium Elafibranor Metformin Embonate Cytarabine Furosemide M-(18F)-Fluorobenzylguanidine TAZAROTENE Ribonucleic Acid K10 Tolvaptan Buspirone Hydrochloride TRAZODONE HYDROCHLORIDE INSULIN DETEMIR Prednisolone Sodium Succinate Bezafibrate Simvastatin Immunoglobulin M More therapies…

    Learn about Your Condition

    Colon cancer stage II Vitiligo SAPHO syndrome Procedural hypotension Cardiac failure congestive Suicidal ideation Chronic sinusitis Essential hypertension Immune thrombocytopenia Intervertebral disc protrusion Fallopian tube cancer Microscopic polyangiitis Embolism Orthostatic hypotension Pseudoxanthoma elasticum More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Azienda Ospedaliera Ospedali Riuniti Villa Sofia Cervello…

Azienda Ospedaliera Ospedali Riuniti Villa Sofia Cervello

Vhq Tkoaifjs 1ngp Pckridtr 9fuqdr Iopqk

Want to learn more about this study or check if you can participate? Contact us.

  • Study of mirikizumab and tirzepatide for adults with moderate to severe Crohn’s disease who are overweight or obese

    Recruiting

    3 1
    Investigated Drugs:
    • Mirikizumab
    • Tirzepatide
    Austria Belgium Bulgaria Czechia Denmark France +9

  • A study to assess the safety of Anumigilimab in adults with sickle cell disease

    Recruiting

    2 1
    Investigated Drugs:
    • ANUMIGILIMAB
    Belgium France Italy The Netherlands

  • Study of glofitamab, obinutuzumab and tocilizumab in patients with mantle cell lymphoma relapsed or refractory after CAR‑T therapy

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Glofitamab
    • Obinutuzumab
    • Tocilizumab
    Italy

  • A study to evaluate the effectiveness of pirtobrutinib in elderly and frail patients with mantle cell lymphoma who have not yet received treatment.

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Mantle cell lymphoma
    Investigated Drugs:
    • Pirtobrutinib
    Italy

  • A study of bleximenib combined with intensive chemotherapy for adults with newly diagnosed acute myeloid leukemia with specific genetic changes.

    Recruiting

    3 1
    Investigated Diseases:
    • Acute myeloid leukaemia
    Investigated Drugs:
    • BLEXIMENIB
    Austria Belgium Denmark Estonia Finland Germany +8

  • A Study of Maribavir for Cytomegalovirus Infection in Stem Cell Transplant Patients Who Cannot Take or Did Not Tolerate Standard Treatment

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Cytomegalovirus infection
    • Allogenic stem cell transplantation
    Investigated Drugs:
    • Maribavir
    Italy

  • A Study of ADX-324 to Prevent Attacks in Patients With Hereditary Angioedema

    Recruiting

    3 1
    Investigated Drugs:
    • ADX-324
    Austria Belgium Bulgaria Croatia Czechia France +5

  • Study comparing daratumumab, lenalidomide and dexamethasone followed by linvoseltamab versus continued initial treatment in newly diagnosed multiple myeloma patients

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Linvoseltamab
    • Lenalidomide
    • Daratumumab
    Austria Belgium Croatia Czechia Denmark Estonia +10

  • Study of tulisokibart compared to placebo in adults with moderate to severe Crohn’s disease

    Recruiting

    3 1
    Investigated Diseases:
    • Crohn’s disease
    Investigated Drugs:
    • Tulisokibart
    Austria Belgium Croatia Czechia Denmark Finland +15

  • Study of rilzabrutinib tablets compared to placebo in adults with warm autoimmune hemolytic anemia

    Recruiting

    3 1
    Investigated Diseases:
    • Autoimmune haemolytic anaemia
    Investigated Drugs:
    • Rilzabrutinib
    Austria Czechia Denmark Germany Greece Hungary +6
1 2 3 … 11
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!